Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04689347
Title 5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA

Facility Status City State Zip Country Details
Fondazione IRCCS Istituto Nazionale dei Tumori RECRUITING Milan 20133 Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field